UBS Maintains Buy on Colgate-Palmolive, Raises Price Target to $95
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Peter Grom has maintained a Buy rating on Colgate-Palmolive (NYSE:CL) and increased the price target from $93 to $95.
January 29, 2024 | 3:51 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UBS has reaffirmed a Buy rating on Colgate-Palmolive and raised the price target to $95, indicating a positive outlook on the stock.
The increase in price target by a reputable analyst like Peter Grom from UBS suggests a bullish outlook on Colgate-Palmolive, which could lead to increased investor confidence and a potential short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100